COMPANY DESCRIPTION Exogenus Therapeutics is a biotechnology company dedicated to advancing innovative healthcare solutions based on extracellular vesicles (EV). Our lead asset, EXO-101, is expected to enter clinical trials in early 2028. Our team is passionate about...

read more